Quantitative proton MRS of cerebral metabolites in laminin α2 chain deficiency
详细信息 查看全文
- 作者：Knut Brockmann ; Peter Dechent ; Carsten Bö ; nnemann ; Gudrun Schreiber ; Jens Frahm ; Folker Hanefeld
- 关键词：Congenital muscular dystrophy ; Laminin α ; 2 chain ; Leukoencephalopathy ; MR spectroscopy
- 刊名：Brain and Development
- 出版年：2007
- 出版时间：July 2007
- 年：2007
- 卷：29
- 期：6
- 页码：357-364
- 全文大小：461 K
文摘
Congenital muscular dystrophy (CMD) due to merosin (laminin α2 chain) deficiency is an autosomal recessively inherited disorder characterized by severe muscular weakness and hypotonia from birth on. Brain involvement is the rule and characterized by variable T2 hyperintensities of white matter which appears swollen on cranial MRI. The pathophysiology of these white matter changes is not clear. In five patients with laminin α2 deficient CMD we performed short-echo time localized proton MRS with determination of absolute metabolite concentrations in grey and white matter. In affected white matter, a consistent pattern of metabolites was detected comprising reduced concentrations of N-acetylaspartate and N-acetylaspartylglutamate, creatine, and phosphocreatine, and to a milder degree of choline-containing compounds. In contrast, concentrations of myo-inositol were in the normal range. Spectra of cortical and subcortical grey matter were normal. The observed metabolite profile is consistent with white matter edema, that is reduced cellular density, and relative astrocytosis. This interpretation is in line with the hypothesis that laminin α2 deficiency results in leakage of fluids across the blood–brain barrier and a histopathological report of astrocytic proliferation in CMD.